Company Profile
Siegfried provides contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms globally. It offers drug substances, including exclusive synthesis that manufactures custom APIs, as well as an API portfolio
Including non-exclusive APIs and pharma-grade substances that focus on anesthetics, pain and addiction treatment applications, and central nervous and respiratory diseases caffeine for human health and nutrition.
Additionally, it offers drug products, including steriles, which includes fill and finish in vials, ampoules, cartridges, and pre-filled syringes. Its portfolio also includes ophthalmics, such as sterile ointments, gels, and suspensions and solutions, inhalation products
Including capsules in medical devices for inhalation applications, oral solid dosage forms, which includes tablets and capsules, and viral vectors, such as AAV and lentiviruses for gene therapy
Technologies with chemistry capabilities, analytical services, formulation technologies, bridging technologies, containment technology, and cell and gene therapies. Founded in 1873, the company is headquartered in Zofingen, Switzerland.